A Phase 3b Study for Management of Ocular Side Effects in Patients with Epidermal Growth Factor Receptor-Amplified Glioblastoma Receiving Depatuxizumab Mafodotin.
Saved in:
| Title: | A Phase 3b Study for Management of Ocular Side Effects in Patients with Epidermal Growth Factor Receptor-Amplified Glioblastoma Receiving Depatuxizumab Mafodotin. |
|---|---|
| Authors: | Vize CJ; Department of Ophthalmology, Hull University Teaching Hospitals NHS Trust, Hull, UK., Kim SK; Department of Ophthalmology and Visual Science, University of Texas McGovern Medical School, Houston, Texas, USA., Matthews T; Birmingham Neuro-Ophthalmology Unit, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Macsai M; Northshore University Health System, Glenview, Illinois, USA., Merrell R; NorthShore University Health System, Evanston, Illinois, USA., Hsu S; The Vivian L. Smith Department of Neurosurgery, University of Texas McGovern Medical School, Houston, Texas, USA., Kundu MG; AbbVie, North Chicago, Illinois, USA., Yoon J; AbbVie, North Chicago, Illinois, USA., Kennedy E; AbbVie, North Chicago, Illinois, USA., Pai M; AbbVie, North Chicago, Illinois, USA., Bain E; AbbVie, North Chicago, Illinois, USA., Lassman AB; Division of Neuro-Oncology, Department of Neurology and the Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons and New York-Presbyterian, New York, New York, USA., Moazami G; Department of Ophthalmology, Columbia University Irving Medical Center, New York, NY, USA. |
| Source: | Ophthalmic research [Ophthalmic Res] 2023; Vol. 66 (1), pp. 1030-1043. Date of Electronic Publication: 2023 May 31. |
| Publication Type: | Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article |
| Journal Info: | Publisher: Karger Country of Publication: Switzerland NLM ID: 0267442 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0259 (Electronic) Linking ISSN: 00303747 NLM ISO Abbreviation: Ophthalmic Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37257422 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Phase 3b Study for Management of Ocular Side Effects in Patients with Epidermal Growth Factor Receptor-Amplified Glioblastoma Receiving Depatuxizumab Mafodotin. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Vize+CJ%22">Vize CJ</searchLink>; Department of Ophthalmology, Hull University Teaching Hospitals NHS Trust, Hull, UK.<br /><searchLink fieldCode="AU" term="%22Kim+SK%22">Kim SK</searchLink>; Department of Ophthalmology and Visual Science, University of Texas McGovern Medical School, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Matthews+T%22">Matthews T</searchLink>; Birmingham Neuro-Ophthalmology Unit, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Macsai+M%22">Macsai M</searchLink>; Northshore University Health System, Glenview, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Merrell+R%22">Merrell R</searchLink>; NorthShore University Health System, Evanston, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Hsu+S%22">Hsu S</searchLink>; The Vivian L. Smith Department of Neurosurgery, University of Texas McGovern Medical School, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Kundu+MG%22">Kundu MG</searchLink>; AbbVie, North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Yoon+J%22">Yoon J</searchLink>; AbbVie, North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Kennedy+E%22">Kennedy E</searchLink>; AbbVie, North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Pai+M%22">Pai M</searchLink>; AbbVie, North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Bain+E%22">Bain E</searchLink>; AbbVie, North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Lassman+AB%22">Lassman AB</searchLink>; Division of Neuro-Oncology, Department of Neurology and the Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons and New York-Presbyterian, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Moazami+G%22">Moazami G</searchLink>; Department of Ophthalmology, Columbia University Irving Medical Center, New York, NY, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220267442%22">Ophthalmic research</searchLink> [Ophthalmic Res] 2023; Vol. 66 (1), pp. 1030-1043. <i>Date of Electronic Publication: </i>2023 May 31. – Name: TypePub Label: Publication Type Group: TypPub Data: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Karger%22">Karger </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>0267442 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1423-0259 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200303747%22">00303747 </searchLink><i>NLM ISO Abbreviation: </i>Ophthalmic Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37257422 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1159/000531142 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1030 Titles: – TitleFull: A Phase 3b Study for Management of Ocular Side Effects in Patients with Epidermal Growth Factor Receptor-Amplified Glioblastoma Receiving Depatuxizumab Mafodotin. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Vize CJ – PersonEntity: Name: NameFull: Kim SK – PersonEntity: Name: NameFull: Matthews T – PersonEntity: Name: NameFull: Macsai M – PersonEntity: Name: NameFull: Merrell R – PersonEntity: Name: NameFull: Hsu S – PersonEntity: Name: NameFull: Kundu MG – PersonEntity: Name: NameFull: Yoon J – PersonEntity: Name: NameFull: Kennedy E – PersonEntity: Name: NameFull: Pai M – PersonEntity: Name: NameFull: Bain E – PersonEntity: Name: NameFull: Lassman AB – PersonEntity: Name: NameFull: Moazami G IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2023 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1423-0259 Numbering: – Type: volume Value: 66 – Type: issue Value: 1 Titles: – TitleFull: Ophthalmic research Type: main |
| ResultId | 1 |